BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 36309620)

  • 21. Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma.
    Huaqi Y; Bingqi D; Yanhui Z; Yongkang M; Shiming Z; Zhenghui S; Zheng D; Jiangshan P; Tiejun Y
    BMC Cancer; 2023 Oct; 23(1):972. PubMed ID: 37828458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoring BARX2 in OSCC reverses partial EMT and suppresses metastasis through miR-186-5p/miR-378a-3p-dependent SERPINE2 inhibition.
    Sun Y; Pan J; Li Y; Hu Y; Ma J; Chen F; Zhang Y; Jiang Z; Zhang J
    Oncogene; 2024 May; ():. PubMed ID: 38719950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction: RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.
    Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38516709
    [No Abstract]   [Full Text] [Related]  

  • 24. miR-425-5p Regulates Proliferation of Bovine Mammary Epithelial Cells by Targeting
    Li Y; Chen G; Xu S; Xia S; Sun W; Wang J; Chen S; Lai S; Jia X
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-378a-3p promotes renal cell carcinoma proliferation, migration, and invasion by targeting TOB2.
    Bao N; Zhang P; Zhu Y; Du P; Jin G; Wu B; Ding T
    Clin Transl Oncol; 2023 Mar; 25(3):748-757. PubMed ID: 36309620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
    Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
    Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis.
    Zhang G; Wang J; Tan W; Han X; Han B; Wang H; Xia Y; Sun Y; Li H
    Acta Histochem; 2021 Sep; 123(6):151752. PubMed ID: 34274607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
    Qi Q; Sun Y; Yang Y; Liu Y
    Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-378a-3p acts as a tumor suppressor in gastric cancer
    Xu X; Li Y; Liu G; Li K; Chen P; Gao Y; Liang W; Xi H; Wang X; Wei B; Li H; Chen L
    Cancer Biol Med; 2022 Oct; 19(12):1662-82. PubMed ID: 36245214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI.
    Soheilifar MH; Pornour M; Saidijam M; Najafi R; Azizi Jalilian F; Keshmiri Neghab H; Amini R
    Bioimpacts; 2022; 12(4):349-358. PubMed ID: 35975203
    [No Abstract]   [Full Text] [Related]  

  • 32. Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake.
    Rysz J; Franczyk B; Rysz-Górzyńska M; Gluba-Brzózka A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.
    Guo F; Estévez-Vázquez O; Benedé-Ubieto R; Maya-Miles D; Zheng K; Gallego-Durán R; Rojas Á; Ampuero J; Romero-Gómez M; Philip K; Egbuniwe IU; Chen C; Simon J; Delgado TC; Martínez-Chantar ML; Sun J; Reissing J; Bruns T; Lamas-Paz A; Moral MGD; Woitok MM; Vaquero J; Regueiro JR; Liedtke C; Trautwein C; Bañares R; Cubero FJ; Nevzorova YA
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.
    Cui J; Yuan Y; Shanmugam MK; Anbalagan D; Tan TZ; Sethi G; Kumar AP; Lim LHK
    Int J Biol Sci; 2021; 17(15):4254-4270. PubMed ID: 34803496
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.